Study Progress in the Application of Liposome as a Bone-Targeting Drug Carrier
Download as PDF
DOI: 10.25236/iclsmh.2019.022
Author(s)
Jian Wang, Yan Duan, Changpeng Xu, Li Gong, Yu Zhang, Limin Cen, and Qiwen Sun
Corresponding Author
Jian Wang
Abstract
As a carrier of bone-targeting drug, liposome has a wide prospect with advantages of increasing the drug effect and less toxic by-effect. After modified by various mechanisms, liposome can carry drugs by active targeting, passive targeting and dual targeting etc. methods and deposits in bones to allow the drug selectively acts on the bone tissue. Currently the active targeting liposome is the key point of clinical study, which means to chemically modify the liposome surface in chemical way, and increase the bone-affinity of liposome. This study basing on the statement above, summarized the application of different liposome carrier drugs, and make a prospect of liposome application.
Keywords
Bone-targeting drug, Liposome carrier, Application study